Status:
COMPLETED
Value of 25 mcg Cortrosyn Stimulation Test
Lead Sponsor:
The Cleveland Clinic
Conditions:
Adrenal Insufficiency
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The diagnosis of secondary AI is vital to prevent catastrophic events in patients. An optimal test should have a very low margin of error with high sensitivity and specificity, be easy and safe to adm...
Detailed Description
The study consisted of two groups of adult patients 18 to 65 years of age. The first group (G1, n=10) included patients with hypothalamic/pituitary disease with at least one pituitary axis deficiency ...
Eligibility Criteria
Inclusion
- hypothalamic-pituitary-adrenal disorders
Exclusion
- under 18 or older than 65 years of age
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01428336
Start Date
September 1 2011
End Date
January 1 2015
Last Update
July 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Department of Endocrinology
Cleveland, Ohio, United States, 44195